Page 14 - CIBERDEM-2015-cast

Organización
PUBLICACIONES MÁS RELEVANTES DEL CIBERDEM DURANTE 2015 SEGÚN FACTOR DE IMPACTO
Publicación
GAULTON K.J., FERREIRA T., LEE Y., RAIMONDO A., MAGI R., RESCHEN M.E. ET AL. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nature Genetics. 2015;47(12):1415-1425.
MARQUARD J., OTTER S., WELTERS A., STIRBAN A., FISCHER A., EGLINGER J. ET AL. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment. Nature Medicine. 2015;21(4):363-376.
GORE A.C., CHAPPELL V.A., FENTON S.E., FLAWS J.A., NADAL A., PRINS G.S. ET AL. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.Endocrine Reviews. 2015;36(6):E1-E150.
CEBOLA I., RODRIGUEZ-SEGUI S.A., CHO C.H.-H., BESSA J., ROVIRA M., LUENGO M. ET AL. TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors. Nature Cell Biology. 2015;17(5):615-626.
DURAN J., GUINOVART J.J. Brain glycogen in health and disease. Molecular Aspects of Medicine. 2015; 46:70-77.
SALVADó L., PALOMER X., BARROSO E., VáZQUEZ-CARRERA M. Targeting endoplasmic reticulum stress in insulin resistance. Trends in Endocrinology and Metabolism. 2015;26(8):438-448.
ZORZANO A., HERNáNDEZ-áLVAREZ M.I., SEBASTIáN D., MUñOZ J.P. Mitofusin 2 as a Driver That Controls Energy Metabolism and Insulin Signaling. Antioxidants and Redox Signaling. 2015;22(12):1020-1031.
MONTANYA E., FONSECA V., COLAGIURI S., BLONDE L., DONSMARK M., NAUCK M.A. HbA1c improvement evaluated by baseline BMI: a meta-analysis of the liraglutide phase 3 clinical trial programme. Diabetes, Obesity & Metabolism. 2015; DOI: 10.1111/dom.12617.
LLAURADó G., SEVASTIANOVA K., SADEVIRTA S., HAKKARAINEN A., LUNDBOM N., ORHO-MELANDER M. ET AL. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism. 2015;100(2):607-616.
DE HOLLANDA A., CASALS G., DELGADO S., JIMéNEZ A., VIAPLANA J., LACY A.M. ET AL. Gastrointestinal hormones and weight loss maintenance following roux-en-Y gastric bypass. Journal of Clinical Endocrinology and Metabolism. 2015;100(12):4677-4684.
Factor Impacto
29,352
28,223
21,059
19,670
10,238 9,392 7,400
6,360 6,209 6,209
14 I Memoria anual 2015 I CIBERDEM